Elsevier

The Lancet

Volume 343, Issue 8913, 25 June 1994, Pages 1618-1620
The Lancet

Public health
Prevalence of hepatitis C antibodies in clinical health-care workers

https://doi.org/10.1016/S0140-6736(94)93064-3Get rights and content

Abstract

Summary

Health-care workers are known to be at risk from occupational transmission of blood-borne viruses, including hepatitis C. There may be serious implications following infection with hepatitis C including possible transmission to patients.

We determined the prevalence of hepatitis C virus (HCV) antibodies among health-care workers at risk of occupational contact with blood and body fluids and among source patients in reported blood-exposure incidents. Anonymised stored blood samples from health-care workers immunised against hepatitis B virus since 1991 (n=1053) and blood samples from source patients in needlestick injuries (retrospective and prospective) since 1989 (n = 373) were analysed. 3 (0·28%) of the serum samples from health-care workers were found to be anti-HCV-positive. 17 (8 5%) of 200 source patients tested retrospectively between January 1989 and January 1992, and 24 (13 9%) of 173 source patients tested prospectively between January 1992 and June 1993 were anti-HCV-positive. During the second period, 15 (10·6%) of 142 source patients tested for human immunodeficiency virus (HIV) were positive and 7 (3·8%) of 184 source patients tested for hepatitis B surface antigen were positive. 6 of 24 (25%) HCV-infected patients were diagnosed only after the incident; for hepatitis B, 2 (33%) of patients were diagnosed after the incident, and for HIV all patients were previously diagnosed.

The seroprevalence of HCV among these health-care workers is no higher than that reported in blood donors. This suggests that there has not been significant occupational transmission of HCV to these health-care workers despite the high prevalence of HCV (often covert) among source patients in reported blood exposure in the same hospital.

References (19)

There are more references available in the full text version of this article.

Cited by (113)

  • An update on the management of hepatitis C: Guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

    2013, Annals of Hepatology
    Citation Excerpt :

    The risk of infection and the associated odds ratio (OR) are as follows: intravenous drug use, OR 49.6; transfusion of infected blood products, OR 10.9 (especially if it occurred before 1992 or 1987 for coagulation concentrates); more than 20 sexual contacts, OR 4.5; sex with an intravenous drug user, OR 6.3; being in prison for > 3 years, OR 2.9; occupational exposure, OR 2.1; piercings or tattoos, OR 2; intravenous immunoglobulin use, OR 1.6; and vertical transmission from mother to child.119 The risk of occupational exposure applies especially to health care workers (HCWs), for whom the estimated prevalence of HCV is 0.28–7.9%.120 The rate of seroconversion after a percutaneous exposure to HCV is 1.8–2.2%;14,15 the highest risk is associated with hollow-bore suture needles, catheterization of a patient’s artery or vein, deep injury, and viremia detected by PCR.121,122

  • The Impact of Rapid Evolution of Hepatitis Viruses

    2008, Origin and Evolution of Viruses, Second Edition
View all citing articles on Scopus
View full text